MSDC 0160
MSDC-0160 is a prototype mTOT-modulating insulin sensitizer being used in trials studying the treatment of Type 2 Diabetes and Alzheimer’s Disease.
| Catalog Number | T2607 |
| Alternative Name(s) | CAY10415 , Mitoglitazone , MSDC0160 , MSDC-0160 |
| Research Area | Others|||Metabolism|||Tyrosine Kinase/Adaptors |
| Molecular Formula | C19H18N2O4S |
| CAS# | 146062-49-9 |
| Purity | 99.45% |
| SMILES | CCc1cnc(cc1)C(=O)COc1ccc(cc1)CC1C(=O)NC(=O)S1 |
| Size | 100 mg |
| Supplier Page | https://www.targetmol.com/compound/MSDC 0160 |
| Additional Information | https://www.targetmol.com/datasheet/T2607 |